Literature DB >> 163607

Type III hyperlipoproteinemia: an analysis of two contemporary definitions.

D S Fredrickson, J Morganroth, R I Levy.   

Abstract

Two current definitions of type III hyperlipoproteinemia, "floating beta" lipoproteins and an estimate of the relative content of cholesterol and triglyceride in lipoproteins of density less than 1,006 (very low-density [VLD] lipoproteins), have been compared. Over 3100 complete lipoprotein analyses of 182 adults with primary familial hyperglyceridemia, covering a wide range of plasma lipid concentrations, formed the data base for this retrospective analysis: The ratio of VLD lipoprotein cholesterol to the plasma triglyceride concentration (VLDL/TG=r) proved capable of segregating an apparently unique subpopulation with persistently abnormal very low-density lipoprotein composition. Although floating beta lipoproteins were present in nearly all patients with a high r value, they also appeared inconsistently in many other patients. It is concluded that the chemical index to VLD lipoprotein composition is the better, albeit, temporary definition for this disorder. When the plasma triglyceride concentration is between 150 and 1000 mg/100 ml, an r not less than 0.25 should be considered as suggestive and a value not less than 0.30 as diagnosttc of type III hyperlipoproteinemia.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 163607     DOI: 10.7326/0003-4819-82-2-150

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  13 in total

1.  Serum apolipoproteins AI and B and lipoproteins in middle aged men with and without previous myocardial infarction.

Authors:  P N Durrington; L Hunt; M Ishola; J Kane; W P Stephens
Journal:  Br Heart J       Date:  1986-09

2.  Evaluation of the classical methods for the diagnosis of type III hyperlipoproteinemia.

Authors:  J R Patsch; R L Jackson; A M Gotto
Journal:  Klin Wochenschr       Date:  1977-11-01

3.  Protease inhibitor related type III hyperlipoproteinaemia is common and not associated with apolipoprotein-E E2/E2 phenotype.

Authors:  M Shahmanesh; H Jaleel; Y DeSilva; J D Ross; M Caslake; R Cramb
Journal:  Sex Transm Infect       Date:  2001-08       Impact factor: 3.519

4.  Plasma and lipoprotein lipid responses to four hypolipid drugs.

Authors:  W R Hazzard; P W Wahl; C Gagne; D Applebaum-Bowden; G R Warnick; J J Albers
Journal:  Lipids       Date:  1984-02       Impact factor: 1.880

5.  [Apolipoproteinopathies].

Authors:  G Assmann
Journal:  Klin Wochenschr       Date:  1983-02-15

6.  Palmar Striated Xanthomas in Clinical Practice.

Authors:  Nathalie Roy; Daniel Gaudet; Diane Brisson
Journal:  J Endocr Soc       Date:  2022-07-02

7.  Human apolipoprotein E isoprotein subclasses are genetically determined.

Authors:  V I Zannis; P W Just; J L Breslow
Journal:  Am J Hum Genet       Date:  1981-01       Impact factor: 11.025

Review 8.  Hyperlipoproteinemia type 3: the forgotten phenotype.

Authors:  Paul N Hopkins; Eliot A Brinton; M Nazeem Nanjee
Journal:  Curr Atheroscler Rep       Date:  2014-09       Impact factor: 5.113

9.  Altered composition of triglyceride-rich lipoproteins and coronary artery disease in a large case-control study.

Authors:  Paul N Hopkins; M Nazeem Nanjee; Lily L Wu; Michael G McGinty; Eliot A Brinton; Steven C Hunt; Jeffrey L Anderson
Journal:  Atherosclerosis       Date:  2009-05-22       Impact factor: 5.162

10.  Clinical features of type III hyperlipoproteinemia: analysis of 64 patients.

Authors:  G Feussner; A Wagner; B Kohl; R Ziegler
Journal:  Clin Investig       Date:  1993-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.